KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Gevo (GEVO) Research & Development (2016 - 2025)

Historic Research & Development for Gevo (GEVO) over the last 16 years, with Q3 2025 value amounting to $1.3 million.

  • Gevo's Research & Development rose 1437.56% to $1.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.5 million, marking a year-over-year decrease of 2715.73%. This contributed to the annual value of $5.6 million for FY2024, which is 1598.61% down from last year.
  • Latest data reveals that Gevo reported Research & Development of $1.3 million as of Q3 2025, which was up 1437.56% from $934000.0 recorded in Q2 2025.
  • Gevo's Research & Development's 5-year high stood at $2.7 million during Q4 2022, with a 5-year trough of $934000.0 in Q2 2025.
  • Moreover, its 5-year median value for Research & Development was $1.5 million (2021), whereas its average is $1.6 million.
  • Per our database at Business Quant, Gevo's Research & Development surged by 13758.62% in 2021 and then crashed by 4308.35% in 2025.
  • Quarter analysis of 5 years shows Gevo's Research & Development stood at $2.6 million in 2021, then increased by 5.33% to $2.7 million in 2022, then decreased by 29.04% to $1.9 million in 2023, then crashed by 33.68% to $1.3 million in 2024, then decreased by 0.08% to $1.3 million in 2025.
  • Its Research & Development stands at $1.3 million for Q3 2025, versus $934000.0 for Q2 2025 and $1.1 million for Q1 2025.